Efficacy and toxicity of stereotactic body radiotherapy for un-resectable stage III non-small cell lung cancer patients unfit for concurrent chemoradiation therapy: a retrospective study

Table 4 Treatment-related toxicities for 213 patients with stage III NSCLC by SBRT [n (%)]. NSCLC, non-small cell lung cancer; SBRT, stereotactic body radiotherapy

Treatment-related toxicities	Grade I	Grade II	Grade III	Grade IV	Grade V
Acute
Neutropenia	11(5.2)	0(0)	0(0)	0(0)	0(0)
Cough	18(8.5)	29(13.6)	0(0)	0(0)	0(0)
Fatigue	43(20.2)	11(5.2)	0(0)	0(0)	0(0)
Radiation oesophagitis	29(13.6)	7(3.3)	0(0)	0(0)	0(0)
Radiation pneumonia	0(0)	15(7.0)	15(7.0)	4(1.9)	1(0.5)
Bronchopulmonary hemorrhage	0(0)	0(0)	4(1.9)	4(1.9)	0(0)
Late
Cough	8(3.8)	4(1.9)	0(0)	0(0)	0(0)
Radiation oesophagitis	4(1.9)	4(1.9)	0(0)	0(0)	0(0)

ISSN: 1748-717X